Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email


Check back regularly for news, coverage, and announcements about MAVA.


Chevy Chase-Based NEA Increases Investment in Blend Therapeutics

New Enterprise Associates (NEA), the Chevy Chase-based venture capital firm, has increased its investment in Blend Therapeutics, part of a new $16 million round for the Massachusetts-based biopharmaceutical firm. NanoDimension led company's second round, which also included participation from Flagship Ventures. Blend said it will use the proceeds to expand its product and business development teams, as well as to advance its lead programs, initially focused on oncology.

Read More